Implanet officially transferred its listing of shares to the Euronext Growth multilateral continuous trading facility.
Here are five key notes:
1. No new shares were issued as a result of the transfer; the transfer occurred within the framework of an admissions procedure for the company's existing shares.
2. The share listing transition will be effective July 11 when the markets open and Implanet's shares will simultaneously be removed from the Euronext regulated market.
3. The company's ISIN code will remain the same and the ticker listing will be ALIMP.
4. The Euronext Growth multilateral continuous trading facility listing will simplify the administrative burden and reduce costs for Implanet.
5. Implanet will continue to draw up its consolidated accounts in accordance with IFRS and publish quarterly revenue. The company will also inform the public of news or information that could impact its share price.
More articles on spine devices:
Mazor Robotics reports $7.1M jump in Q2 revenue, 19 spine robotic system orders: 5 key notes
Medtronic, DePuy Synthes, Smith & Nephew & more: 14 device company key notes
Intellirod Spine acquires new intellectual property: 5 key points